Evidence level: C
橙黄镜片挡蓝的同时也把总光量降了。「光谱有效」这个结论里,有多少是颜色立了功、有多少只是变暗了——这件事至今没人算过账。而账其实是能算的。
正文
上一篇把话说到了这一步:既往所有”蓝光阻断有效”的研究,几乎都没做强度匹配——滤片在挡蓝的同时,也一起削掉了到达视网膜的明视觉与黑视素光子通量,两个变量被绑在一起动。于是就留下一个没法回避的追问:那些效应量里,究竟有多少是”颜色”贡献的?
这件事的雏形其实已被做出一半。Chin 等人 2026 年的实测(PMID 41565717)把 52 件灯具逐一测了褪黑素抑制值(MSV)与黑视素照度:冷白 LED 中位 12.3%、冷白节能灯 12.1%,暖白 LED 3.6%、暖白节能灯 2.6%、白炽灯 1.5%;可调色温灯从 5700 K 的 10% 一路降到 2100 K 的 0.1%;8 片蓝光过滤镜片里,6 片”相对于透明镜片收益有限”,只有 2 片棕色染色片能把估算抑制压到 0.3% 以下。这张表就是混杂矩阵的第一根轴——它同时给了每件器具的明视觉透射与黑视素透射。但它停在”报数”,没做分解:没人把这两个数除一下,看看”选择性”到底是几。
第一刀:色温不能当代理,这条先要钉死。 用”3000 K 护眼”来推断生物效力是无效的。同一套五通道可调 LED 的模拟显示(PMID 36418869):在 300 lx、显色指数 Rf≥70 的条件下,色温从 2500 K 扫到 6000 K,节律刺激量 CS 从 17% 跨到 41%;更要命的是在同一个 5000 K 色温上,仅因光谱配比不同,黑视素等效照度就能从 196 lx 变到 319 lx——差了 123 lx,六成。所以任何一张混杂矩阵的横轴都必须是黑视素等效照度(mEDI),不能是色温或 lux。
第二刀:分解本身是初等代数,只是没人写过。 设滤片对某光源的明视觉透射率为 T_v、黑视素透射率为 T_mel,定义选择性 r = T_mel / T_v。因为 mEDI 是乘性的,取对数就能把两条路干净拆开:
纯光谱份额 = |ln r| / |ln T_mel|
强度份额 = |ln T_v| / |ln T_mel|
代入第一轴那张表的量级(透射率取该档典型值):清透片 T_v≈0.92 / T_mel≈0.90,r≈0.978——纯光谱只占 21%,八成效应其实是”变暗”;浅黄片 T_v≈0.85 / T_mel≈0.62,r≈0.729——纯光谱 66%,强度 34%;深棕片 T_v≈0.55 / T_mel≈0.05,r≈0.091——纯光谱升到 80%。
这里浮出一个反直觉的结论:越是”温和、日常能戴”的镜片,被强度混杂得越狠。 清透片和淡黄片贡献了 Cochrane 那 17 项 RCT 里的大部分样本(PMID 37593770,睡眠结局”极低确定性”、无一项测血清褪黑素),而它们的效应量里三分之二到五分之四来自”顺带变暗”。这恰好解释了为什么消费品级研究的效果总比实验室级弱——实验室用的是精心反向补偿的同色异谱对(PMID 29984614,175 lx/2700 K 全匹配,仅调 450-500 nm 功率,抑制从近 50% 掉到与暗光无差异),那里 T_v 被硬按在 1,混杂份额是零。
第三刀最狠:把 mEDI 匹配上之后,颜色本身就不起作用了。 16 名受试者的重复测量(PMID 38135734):三组光照的黑视素激发全部相等,但明视觉照度分别是 93.5、123.5、67.0 lux(相差近两倍),蓝-黄轴方向也相反——结果在褪黑素相位延迟、抑制幅度、主观嗜睡、警觉性上均无差异。48 人的另一项非视觉同色异谱研究(PMID 40687802)用贝叶斯分析给出更明确的否定:锥体调制对褪黑素抑制与警觉性无可测贡献。
这两条合起来的意思必须说透:一旦 mEDI 相等,光谱形状就不再单独产生影响。 所以严格讲,”纯光谱效应”不是独立效力,而是同效下的视觉代价折扣。滤片之所以”有效”,是因为它把 mEDI 降下来了;它比”把灯调暗”优越的地方,只是少牺牲明视觉。这个区分有实际后果——所有”低蓝光更健康”的说法,真正的剂量变量是 mEDI 那个数,不是”蓝不蓝”。
第四刀:矩阵必须是二维的,因为斜率不是常数。 29 篇文献的机器学习汇总(PMID 34981572)确认 mEDI 是最佳单一预测因子,但补了一句关键限定:在 21 lx 以下,S 视锥等效照度反超 mEDI 成为更优预测因子。瞳孔研究也印证剂量与效应的耦合不是线性的(PMID 38348477,72 人、五原色显示、L/M/S 匹配只变黑视素约 3 倍,瞳孔随 mEDI 单调收缩)。所以混杂份额会随剂量区间漂移,一张 滤片 × 剂量区间 的二维表才是可用的。
据此,反推公式与判决设计可以写死。 若已发表研究报了效应量 Δ,要拆出纯光谱贡献,需拿到三样东西:该镜片的实测 τ(λ)、研究中受试者眼位 mEDI 记录、以及该剂量区间的斜率 f′(mEDI)。则”若只改色不改亮”的等效 mEDI 保留率应取 r 而非 T_mel,两者之差乘斜率即为强度混杂的量。实验上对应的判决:同一批商用滤片与实验级同色异谱对做头对头光学标定,每件测光谱透射曲线、明视觉透射率、mEDI 透射率、以及固定 mEDI 下被一并削掉的明视觉比例,输出二维混杂矩阵;再回溯分解已发表的 BB 研究。
对”天人相应”的意义: 风水讲”卧室宜暖不宜冷””灯不要正对床头”,历来只有口诀。这张矩阵给的是可证伪版本——它不问”暖色好不好”,只问:给定你要把黑视素剂量降到多少,市面上哪件器具能在视觉代价最小处落到那个点上? 答案不是”越黄越好”(棕染片 T_mel≈0.05 是过度),而是中间那条窄带。
L1 网络状态:该主题尚未进入 L1 对应网络。CORRESPONDENCE_NETWORK.md 与 EDGE_TABLE_science-yixue.md 中均无「光照强度/光谱—生理节律」相关边(概念计数仅见「光波长/色温」作为物理侧节点列出,无对应边条目),本文所用分解为自建代数推导,无 L1 边支撑,证据等级封顶 C。
证据与局限
已验证: 色温不能作为生物效力代理,同色温下 mEDI 可差六成(PMID 36418869);黑视素等效照度是最佳单一预测因子,但 21 lx 以下 S 视锥指标更优(PMID 34981572);等 mEDI 条件下蓝-黄方向与明视觉照度差异不产生可测的节律结局差异(PMID 38135734);锥体调制对夜间褪黑素与警觉性无可测贡献(PMID 40687802);滤片与灯具的实测透射差异确实巨大(PMID 41565717)。
部分验证: 同色异谱可在照度色温全匹配下单独改变褪黑素抑制(PMID 29984614)——但该设计恰恰把 T_v 固定在 1,故它证明的是”光谱能起作用”,不能证明”消费品级滤片的光谱选择性有效”;mEDI 与瞳孔、与睡眠潜伏期存在剂量依赖(PMID 36854795、PMID 38348477),但均在 ≤90 lx 的低照度区测得。
待验证: 纯光谱份额的对数分解公式尚无任何已发表研究采用,本文给出的 21%/66%/80% 三档为按典型透射率代入的量级估算,非实测;各档滤片的真实 τ(λ) 与 T_v、T_mel 配对值缺失;剂量区间导致的斜率漂移幅度未知;无任何一项已发表 BB 研究同时报告了镜片 τ(λ) 与受试者眼位 mEDI,故反推在当前文献条件下实际不可执行。该主题整体证据薄弱,本文属研究设计讨论。
相关阅读
- 只改颜色不改亮度,能不能救回天人相应:蓝光阻断与同色异谱的光谱隔离判决实验
- 光照的时长与强度是两条腿还是同一条腿:两因素交互的判决设计
- 个体光照剂量-效应曲线:如何用光传感器把「天人相应」从拼接变成实测
- 眼睑透射与视网膜黑视素剂量衰减
- 研究池子 P0:环境-生命频率接口
证据等级: C
参考文献: PMID 41565717, PMID 36418869, PMID 38135734, PMID 40687802, PMID 34981572, PMID 38348477, PMID 29984614, PMID 36854795, PMID 37593770
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Does Blue Light Blocking Filter Out Blue or Dim the Light: A Hybrid Matrix Separates Spectral and Intensity Effects
Evidence level: C
Orange-yellow lenses block blue light but also reduce total luminous flux. Within the conclusion of “spectral efficacy,” how much is due to color and how much is simply because it got darker—this accounting has never been done. Yet the accounting is possible.
Main Text
The previous discussion reached this point: all prior studies claiming “blue light blocking is effective” failed to match intensity—filters block blue but simultaneously cut the photopic and melanopic photon flux reaching the retina, binding two variables together. This leaves an unavoidable question: of those effect sizes, how much is actually contributed by “color”?
A prototype of this analysis has already been completed halfway. Chin et al.’s 2026 measurement (PMID 41565717) tested the melatonin suppression value (MSV) and melanopic illuminance of 52 luminaires: cold white LED median 12.3%, cold white CFL 12.1%, warm white LED 3.6%, warm white CFL 2.6%, incandescent 1.5%; tunable color temperature lights dropped from 10% at 5700 K to 0.1% at 2100 K; among 8 blue-filtering lenses, 6 showed “limited benefit compared to clear lenses,” and only 2 brown-tinted lenses could suppress the estimated inhibition below 0.3%. This table forms the first axis of the mixed matrix—it provides both photopic transmittance and melanopic transmittance for each device. However, it stops at “reporting numbers” without decomposition: no one divides these two values to determine the exact “selectivity.”
First cut: Color temperature cannot serve as a proxy; this must be firmly established. Inferring biological efficacy from “3000 K eye-care” is invalid. Simulation of a five-channel tunable LED system (PMID 36418869) shows that under 300 lx with Rf≥70, varying color temperature from 2500 K to 6000 K changes the circadian stimulus CS from 17% to 41%. More critically, at the same 5000 K color temperature, differing spectral ratios cause melanopic equivalent illuminance (mEDI) to vary from 196 lx to 319 lx—a difference of 123 lx, or 60%. Therefore, the x-axis of any mixed matrix must be melanopic equivalent illuminance (mEDI), not color temperature or lux.
Second cut: Decomposition itself is elementary algebra, just never written down. Let T_v be the photopic transmittance and T_mel the melanopic transmittance of a filter for a given light source, defining selectivity r = T_mel / T_v. Since mEDI is multiplicative, taking logarithms cleanly separates the two pathways:
Pure spectral share = |ln r| / |ln T_mel|
Intensity share = |ln T_v| / |ln T_mel|
Substituting magnitudes from the first axis table (using typical transmittance values): clear lens T_v≈0.92 / T_mel≈0.90, r≈0.978—pure spectral contribution only 21%, eightfold effect actually “dimming”; light yellow lens T_v≈0.85 / T_mel≈0.62, r≈0.729—pure spectral 66%, intensity 34%; deep brown lens T_v≈0.55 / T_mel≈0.05, r≈0.091—pure spectral rises to 80%.
This yields a counterintuitive conclusion: the more “gentle, everyday-wearable” lenses are the most contaminated by intensity mixing. Clear and light yellow lenses contributed most samples in Cochrane’s 17 RCTs (PMID 37593770, sleep outcomes “very low certainty,” none measured serum melatonin), yet two-thirds to four-fifths of their effect sizes stem from “incidental dimming.” This precisely explains why consumer-grade studies show weaker effects than lab-grade ones—lab studies use carefully matched isochromatic pairs (PMID 29984614, 175 lx/2700 K full match, adjusting only 450-500 nm power, inhibition dropped from nearly 50% to indistinguishable from dark), where T_v is rigidly fixed at 1, making the intensity mixing share zero.
Third cut is most severe: once mEDI is matched, color itself becomes irrelevant. Repeated measurements of 16 subjects (PMID 38135734): three lighting conditions had identical melanopic excitation but photopic illuminance differed at 93.5, 123.5, and 67.0 lux (nearly twofold difference), with blue-yellow axis direction reversed—yet no differences emerged in melatonin phase delay, inhibition amplitude, subjective sleepiness, or alertness. Another 48-subject non-visual isochromatic study (PMID 40687802) using Bayesian analysis provides clearer negation: cone modulation contributes nothing measurable to melatonin suppression or alertness.
These two findings must be made explicit: once mEDI is equal, spectral shape no longer independently affects outcomes. Strictly speaking, “pure spectral effect” is not independent efficacy but visual cost discounting under equivalent conditions. Filters appear “effective” because they reduce mEDI; their advantage over “dimming the light” is merely sparing photopic vision. This distinction has practical consequences—all claims of “low blue is healthier” actually have mEDI as the true dose variable, not “how blue it is.”
Fourth cut: The matrix must be two-dimensional because slope is not constant. Machine learning synthesis of 29 studies (PMID 34981572) confirms mEDI is the best single predictor, but adds the crucial caveat: below 21 lx, S-cone equivalent illuminance surpasses mEDI as the superior predictor. Pupil research also confirms dose-effect coupling is not linear (PMID 38348477, 72 subjects, five primary colors, L/M/S matching changed melanopic only ~3-fold, pupils monotonically contracted with mEDI). Thus mixing shares drift across dose intervals; only a filter × dose interval two-dimensional table is usable.
Accordingly, reverse-engineering formulas and judgment designs can be fixed. If published studies report effect size Δ, extracting pure spectral contribution requires three elements: the filter’s measured τ(λ), the study subjects’ eye-position mEDI records, and the slope f′(mEDI) for that dose interval. Then “changing color without changing brightness” equivalent mEDI retention should use r rather than T_mel, with the difference multiplied by slope giving intensity mixing magnitude. Experimental judgment: head-to-head optical calibration of commercial filters against lab-grade isochromatic pairs, measuring spectral transmittance curves, photopic transmittance, mEDI transmittance, and the proportion of photopic vision sacrificed under fixed mEDI, outputting a two-dimensional mixing matrix; then back-calculating decomposition of published BB studies.
Significance for “天人相应” (Yijing Studies): Feng Shui traditionally states “bedrooms should be warm not cold, lights should not face the headboard”—only mnemonic rules. This matrix provides a falsifiable version—it doesn’t ask “is warm color good,” but rather: given you want to reduce melanopic dose to X, which commercial device lands there with minimal visual cost? The answer is not “the yellower the better” (brown-tinted T_mel≈0.05 is excessive), but that narrow middle band.
L1 Network Status: This topic has not yet entered the L1 corresponding network. Neither CORRESPONDENCE_NETWORK.md nor EDGE_TABLE_science-yixue.md contains edges related to “light intensity/spectrum—physiological rhythm” (concept counting only lists “wavelength/color temperature” as physical-side nodes, with no corresponding edge entries). The decomposition used here is self-constructed algebraic derivation, lacking L1 edge support; evidence level capped at C.
Evidence and Limitations
Verified: Color temperature cannot serve as a proxy for biological efficacy; under identical color temperature, mEDI can differ by 60% (PMID 36418869); melanopic equivalent illuminance is the best single predictor, though below 21 lx S-cone metrics are superior (PMID 34981572); under equal mEDI conditions, blue-yellow axis direction and photopic illuminance differences produce no measurable circadian outcome variation (PMID 38135734); cone modulation contributes nothing measurable to nighttime melatonin suppression or alertness (PMID 40687802); measured transmittance differences between filters and luminaires are indeed substantial (PMID 41565717).
Partially verified: Isochromatic pairs can independently alter melatonin suppression under full illuminance/color temperature matching (PMID 29984614)—but this design fixes T_v at 1, proving “spectral effects work” but not “consumer-grade filter spectral selectivity works”; mEDI and pupil size, and sleep latency, exhibit dose-dependence (PMID 36854795, PMID 38348477), but all measured in low-illuminance regions ≤90 lx.
To be verified: Logarithmic decomposition formulas for pure spectral share have not been adopted in any published study; the 21%/66%/80% tiers presented here are magnitude estimates based on typical transmittance substitution, not measured values; true τ(λ) and T_v/T_mel pairing values for each filter tier are missing; slope drift magnitude due to dose intervals is unknown; no published BB study simultaneously reports lens τ(λ) and subject eye-position mEDI, making reverse calculation practically unfeasible under current literature conditions. Overall evidence for this topic is weak; this article constitutes research design discussion.
Further Reading
- Changing color without changing brightness, can it restore 天人相应:Spectral isolation judgment experiment of blue light blocking and isochromatic coupling
- Duration and intensity of light exposure: two legs or one leg? Judgment design of two-factor interaction
- Individual light dose-response curves: How to transform “天人相应” from assembled to measured using light sensors
- Eyelid transmittance and retinal melanopic dose attenuation
- Research pool P0: Environment-life frequency interface
Evidence Level: C
References: PMID 41565717, PMID 36418869, PMID 38135734, PMID 40687802, PMID 34981572, PMID 38348477, PMID 29984614, PMID 36854795, PMID 37593770
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply